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Summary 
This paper details an in-vitro study using human adipose tissue-derived precursor/stem 
cells (ADSCs) in three-dimensional (3D) tissue culture systems. ADSCs from 3 donors 
were seeded onto NaOH-treated medical grade polycaprolactone-tricalcium phosphate 
(mPCL-TCP) scaffolds with two different matrix components; fibrin glue and lyophilized 
collagen. ADSCs within these scaffolds were then induced to differentiate along the 
osteogenic lineage for a 28-day period and various assays and imaging techniques were 
performed at Day 1, 7, 14, 21 and 28 to assess and compare the ADSC’s adhesion, 
viability, proliferation, metabolism and differentiation along the osteogenic lineage when 
cultured in the different scaffold/matrix systems.  
 
The ADSC cells were proliferative in both collagen and fibrin mPCL-TCP scaffold 
systems with a consistently higher cell number (by comparing DNA amounts) in the 
induced group over the non-induced groups for both scaffold systems. In response to 
osteogenic induction, these ADSCs expressed elevated osteocalcin, alkaline phosphatase 
and osteonectin levels. Cells were able to proliferate within the pores of the scaffolds and 
form dense cellular networks after 28 days of culture and induction. 
 
The successful cultivation of osteogenic ADSCs within a 3D matrix comprising fibrin 
glue or collagen, immobilized within a robust synthetic scaffold is a promising technique 
which should greatly enhance their potential usage in the regenerative medicine arena, 
such as bone tissue engineering.  
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Introduction 
Like bone marrow, adipose tissue is derived from the embryonic mesenchyme and 
contains a heterogenous stem cell population [1,2]. Adipose tissue can be obtained via 
liposuction with relative ease and minimal discomfort and most significantly, can yield 
clinically relevant stem cell numbers after isolation [3]. Many terminologies are used to 
refer to this cell population, including human adipose tissue-derived precursor cells, for 
the purpose of this paper, we will refer to this cell population as adipose tissue-derived 
stem cells (ADSCs), a term which is increasingly adopted in current literature [2,4]. 
ADSCs were isolated from human lipoaspirates. Similar to BMSCs, ADSCs have the 
capabilities to differentiate towards osteogenic, adipogenic, myogenic, chondrogenic and 
even neurogenic lineages [4]. An in-depth understanding of ADSC differentiation, in 
particular along the osteogenic lineage, will greatly enhance the potential application of 
ADSCs in regenerative medicine, particularly in bone tissue engineering applications.  
 
Previous studies have investigated the cellular behaviour of ADSCs from a 2-dimensional 
perspective. With biomedical research rapidly progressing towards the simulation of in 
vivo environments with in vitro cell culture systems, there is a real need to extend these 
studies to investigate ADSCs within a 3D system [5]. Currently, porous scaffolds and/or 
hydrogels are being employed in tissue engineering techniques to serve as 3D supports 
for initial cell attachment and subsequent tissue formation both in vitro and in vivo. 
Hence, one aspect of this investigation was to assess the effects of adding lyophilized 
collagen to currently used mPCL-TCP scaffolds and how this might affect the 
attachment, proliferation and osteogenic differentiation of ADSCs. Fibrin glue was used 
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as a cell delivery vehicle to encapsulate ADSCs within the scaffolds via the pre-mixing of 
the fibrin glue components with ADSCs and the immediate, subsequent polymerization 
of the fibrin when added to the mPCL-TCP scaffolds. Control scaffolds were mPCL-TCP 
with no added collagen, only fibrin glue with ADSCs.  Studies have shown that fibrin 
glue can improve the stability and cell-attachment properties of scaffolds, and hence 
enhances cell seeding efficiency as well as subsequent cell proliferation [6]. Collagen is 
an important constituent of cell extracellular matrix (ECM) and remains relatively 
unexplored as a matrix system to enhance the cell-attachment properties in the context of 
3D scaffolds, until recently [7, 8]. It is therefore of interest to investigate the potential to 
culture ADSCs within 3D scaffolds and to study their osteogenic potential within this 3D 
environments with an ultimate aim at bone tissue engineering applications. In addition to 
this we also compare the efficacies of lyophilized collagen to that of fibrin glue as matrix 
systems within these 3D scaffolds. 
  
In this study, ADSCs seeded onto either mPCL-TCP)-collagen or mPCL-TCP-fibrin 
scaffolds were induced along the osteogenic linage for a 28-day period by a combination 
of 1α, 25-dihydroxyvitamin D3, β-glycerophosphate and ascorbic acid. Various assays 
and imaging techniques were performed, including alamar blue, picoGreen, alkaline 
phosphtase, osteocalcin ELISA, protein quantification and western blotting and light, 
confocal and scanning electron microscopy, at various time points to assess and compare 
ADSCs’ adhesion, viability, proliferation, metabolism and differentiation along the 
osteogenic lineage, within the respective scaffolds. 
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Materials & Methods 
Cell Isolation & Culture 
Human adipose tissue was obtained from abdominal regions of female adult donors (aged 
30-50) undergoing elective liposuction, after informed consent and approval by the 
Institutional Review Board, National University Hospital. The adipose tissue was so 
obtained processed using a modified protocol from Zuk et al [4] to obtain a population of 
cells termed processed lipoaspirates or ADSCs. 
 
The adipose tissue was first washed with phosphate buffered saline solution (PBS) across 
a separating sieve to remove contaminating debris and red blood cells (all reagents and 
solutions were from Gibco® unless stated otherwise). The tissue was then digested with 
0.075% collagenase type I (Sigma-Aldrich, St. Louis, MO) at 37°C for 1 hour in an oven 
with constant shaking. The digestion process was stopped with equal volume of 
Dulbeco’s Modified Eagle’s Medium (DMEM) supplemented with fetal bovine serum. 
Cells were pelleted by centrifugation at 1,200×g at 4°C for 10 minutes and then plated on 
culture flasks (TPP, Trasadingen, Switzerland). ADSCs were cultured in growth media 
(DMEM supplemented with 10% fetal bovine serum (FBS), 1% antibiotics (penicillin 
and streptomycin)) and kept in a sterile incubator with 5% CO2 at 37oC. Media was 
changed every 4th day until  80% confluence. Passage 4 or 5 cells were used in this study. 
 
Lyophilization of collagen onto mPCL-TCP scaffolds  
Medical Grade poly (ε-caprolactone)-tricalcium phosphate (mPCL-TCP) scaffold sheets 
measuring 100 x 100 x 1.5 mm, of lay-down pattern 0/90° (scaffold strut-layers produced 
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at right angles to the previous layer) with a porosity of 70% were purchased from 
Osteopore International, Singapore. Sheets were cut into 5x5x1.5mm (length, breadth and 
height) specimens. The surfaces of all specimens were treated in 5M NaOH for 3 hours to 
enhance cell attachment [15]. Extensive washing with PBS was undertaken to remove 
residual NaOH. Scaffolds were then sterilized with 70% ethanol and washed with sterile 
PBS before being transferred to a 37oC incubator for drying.  
 
The mPCL-TCP collagen matrix system was prepared by the additions of 120 µl bovine 
dermis acid-solubilized type I collagen solution (Koken Cellgen 1-AC, Japan) and 3.2 µl 
Na2CO3, onto each mPCL-TCP scaffold. The scaffolds were kept at   -80oC for 72 hours 
before being lyophilized at -50oC for 24 hours. The scaffolds were then subjected to 
ultraviolet irradiation for 30 minutes to ensure sterility.  
 
Cell Seeding and osteoinduction culture 
For the mPCL-TCP-fibrin scaffold group, ADSCs were introduced into the scaffolds 
using fibrin glue as the carrier (Baxter® Tisseel VH, USA ),which was prepared by 
mixing fibrinogen and thrombin solutions in situ. Fibrinogen was reconstituted with 2 ml 
of fibrinolysis inhibitor solution (3000 KIU/ml aprotinin) to yield the sealer protein 
solution of concentration 75 mg/ml. Thrombin was reconstituted with 2 ml sterile 
calcium chloride solution (40 µmol/ml) to achieve a concentration of 400 IU/ml. ADSC 
cells (in pellet form) were added to the thrombin solution to obtain 30,000 cells/µl. 
Thirteen µl each of fibrinogen solution and of cell-thrombin mixture were added onto 
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each mPCL-TCP scaffold and allowed to polymerize, thus encapsulating the cells within 
the matrix.  
For the mPCL-TCP-collagen group, cells in DMEM/10%FBS media were seeded directly 
onto the lyophilized collagen. The collagen upon contact with the cell suspension 
hydrated and formed a gel like matrix encapsulating the cells within the scaffolds.    
Scaffold/cell constructs from each group were placed in well plates and incubated for one 
hour at 37oC/5% CO2 prior to growth media top-up. 
Osteogenic induction was then implemented after 8 days in culture (hereby defined as 
Day 0). ADSCs in the non-induced group were cultured with normal growth media 
(DMEM). The supplements for the osteo-induced groups were: 0.01 μM 1α,25-
dihydroxyvitamin D3, 50 M ascorbate-2-phosphate, 10 mM -glycerophosphate 
(Sigma-Aldrich, USA). 
 
Alamar Blue (AB) Metabolic Assay 
The AB assay (Biosource International Inc., USA) was undertaken to assess the metabolic 
activity of the cells at day 1, 14, and 28 of induction for both the osteogenically-induced 
and non-induced (control) scaffold groups (for each group n=5). The assay incorporates a 
light absorbance growth indicator which changes colour in response to chemical 
reduction of the AB-spiked growth media resulting from cell metabolism. This assay 
therefore indirectly measures cell number increases. Briefly, media was replaced with 
10% v/v alamarBlue®(AB)-fresh media mixture and incubated for 3 hours at 37oC/5% 
CO2. The mixture was aliquoted into a 96-well plate in triplicates and its absorbance was 
measured 560nm and 595nm. 
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PicoGreen Assay: DNA Quantification 
At each respective time point, the scaffolds were broken into small pieces with scissors, 
using liquid nitrogen to facilitate the release of DNA from cells to obtain homogenous 
suspensions. Briefly, scaffolds from the osteogenically-induced and non-induced groups 
(each n=4) were collected at Day 14 & 28 of induction, washed in PBS and snap-frozen 
in liquid nitrogen. They were cut into smaller pieces, suspended in 200 µl of autoclaved 
deionized water and wrapped with three layers of aluminum foil and subjected to 3 cycles 
of freezing-thawing in liquid nitrogen. Aliquots of the supernatant were then taken and 
DNA contents were quantified using PicogreenTM (Molecular Probes Inc., USA), 
according to the manufacturers’ instructions. Samples were incubated with 1 ml of 
PicogreenTM working solution (dilution 1:200) for 5 minutes at room temperature. The 
fluorescence of the DNA mixture was measured at excitation and emission wavelengths 
of 485 nm and 535 nm respectively. 
 
Alkaline Phosphatase (ALP) Assay 
Supernatants from the osteogenically-induced and non-induced groups (n=5) were 
collected at Day 1, 7, 14, 21 & 28 of induction. A standards curve of absorbance versus 
ALP concentration were constructed by using standards of known ALP concentration (0, 
2, 20, 50, 80 and 140 U/L) from the BAP EIA kit (Quidel Corporation, USA). 5 µl of 
each standard were diluted with 45 µl of induction media to make up a total volume of 50 
µl. 2 blanks consisting of 50 µl of induction media were also included to ascertain 
contributing ALP levels from the media. Aliquots of 50 µl of samples, blank media or 
standards were incubated with 150 µl of 0.2% p-nitrophenyl phosphate (Sigma-Aldrich, 
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USA) substrate solution for 20 minutes at 37°C. The reaction was stopped with NaOH 
solution (final concentration 0.6N). 100 µl of the mixture was added to a 96-well plate in 
triplicate. The production of p-nitrophenol was measured by monitoring absorbance at 
405 nm using a spectrometer. 
 
Osteocalcin ELISA 
Osteocalcin activity was measured by using a human osteocalcin ELISA kit (DSL, USA). 
Supernatants from the osteogenically-induced and non-induced groups (each n=5) were 
collected at Day 1, 7, 14, 21 & 28 of induction. 100 µl of the reconstituted standards and 
the sample supernatants of unknown osteocalcin concentrations were incubated at room 
temperature in a 96-well plate which had been pre-coated with anti-osteocalcin 
monoclonal antibody, followed by the addition of 100 µl secondary polyclonal antibody, 
labeled with the enzyme horseradish peroxidase for 2 hours. During incubation, the 96-
well plate was subjected to fast shaking at a speed of 500 rpm on an orbital microplate 
shaker. After incubation and washing, each well was incubated with 100 µl of the 
chromogenic substrate tetramethylbenzidine and 100 µl of an acidic stopping solution 
(0.2 M sulfuric acid) was then added to each well. The degree of enzymatic turnover of 
the substrate was determined by absorbance measurement at 450 nm.  
Protein Extraction & Quantification 
Protein extraction were performed on scaffolds from the osteo-induced and non-induced 
groups (each n=3) at Day 28 of induction. Briefly, the scaffolds were submerged in PBS 
for 1 hour to remove any FBS from the media, and dried. They were cut into smaller 
pieces, suspended in 100 µl of lysis buffer (50mM Tris-Cl (pH 8.0), 150mM NaCl, 0.1% 
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sodium dodecyl sulfate, 1% Nonidet P-40, 0.5% w/v sodium deoxycholate with protease 
inhibitors (Protease Inhibitor Cocktail (Sigma-Aldrich, P8340, USA)), vortexed and 
stored on ice for 10 minutes. The mixtures were then centrifuged at 18,000 rpm at 4°C 
for 10 minutes, after which the supernatants containing extracted proteins were aliquoted 
out and quantified using Micro BCATM protein assay kit (Pierce Biotechnology, USA) 
according to the manufacturers’ instructions. The absorbance of the protein mixture was 
measured at 562 nm. 
 
Western Blot 
Western blotting was performed on extracted protein samples from the osteo-induced and 
non-induced groups (each n=3) at Day 28 of induction. Protein (50µg each) were 
separated electrophoretically by SDS-polyacrylamide (12%) gel electrophoresis and 
transferred to nitrocellulose membranes. Membranes were incubated with Rabbit 
antibodies for human osteonectin (Santa Cruz Biotechnology Inc, USA, SC–25574). The 
membrane was stripped with Restore Western Blot Stripping Buffer (Pierce, USA) and 
reprobed with human beta actin (Delta Biolabs, USA, DB–070). Bound antibodies were 
visualized with peroxidase-conjugated goat anti-rabbit IgG (Zymed Invitrogen, USA) 
using the SuperSignal West  Pico Substrate (Pierce, USA, #34080).  
Light and Laser Microscopy 
The different morphologies and proliferation of ADSC cells within scaffolds were 
routinely observed using an optical light microscope (Leica DM IRB, Germany). The 
distribution of viable [fluorescein diacetate (FDA)] and dead [propidium iodide (PI)] 
labeled ADSCs within the scaffolds at Day 14 & 28 of induction was observed using a 
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confocal laser microscope (Zeiss LSM510 META, Germany). The scaffolds were 
submerged in 1 ml 20x dilution (in PBS) FDA stain (50 µg/ml) and incubated for 10 
minutes at 37ºC. The scaffolds were then washed in PBS 3 times before being submerged 
in 1 ml 20 x dilution (in PBS) PI stain (50 µg/ml) for 2 minutes at room temperature. 
They were then washed in PBS before being mounted and viewed using the confocal 
laser microscope.  FDA emission was measured at 510 nm – 560 nm (excitation at 
488nm), and PI emission measured at 560 nm – 600 nm (excitation at 543 nm). 
 
Scanning Electron Microscopy (SEM) 
Surface topographies of gold-coated cell-scaffold constructs at Day 14 & 28 of induction 
for the study, were observed using scanning electron microscopy (SEM) (JEOL 
JSM5600, Japan). The scaffolds were first washed with sterile PBS and then fixed in 
2.5% glutaraldehyde for 1 hour at room temperature, they were then subsequently 
dehydrated through an ascending ethanol series at room temperature as follows: 25%, 
50%, 75%, 95%, and 100% ethanol for 10 min each. The scaffolds were then dried and 
transferred to a desiccator with silica gel overnight to ensure no moisture contamination. 
Samples were mounted onto aluminum SEM studs using carbon adhesive tabs and coated 
with a thin layer of gold. 
 
Statistical analysis 
Student’s t-tests were used to statistically assess the significance of differences between 
the induced and non-induced groups and between the time points for the same donor’s 
cell populations. Comparisons with p-values lower than 0.05 were considered significant.
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Results 
Alamar Blue (AB) Metabolic Assay 
The metabolic activity as of the ADSCs seeded upon the respective scaffolds was 
measured using the AB reduction assay at specific time points (Day 1, 14 and 28). Each 
sample/scaffold was subsequently expressed as a ratio of their respective non-induced 
cell population and is depicted in Fig. (1). These normalized ratios showed consistently 
higher values (normalized ratio > 1 – bold line Fig. (1)) for the osteo-induced cells seeded 
in both the mPCL-TCP-fibrin (Fig. (1a)) and mPCL-TCP-collagen scaffolds (Fig. (1b)) 
compared to the corresponding non-induced samples, and showed a similar trend for all 3 
donors (named as P1, P2, P3) analyzed in both scaffold systems. In the case of mPCL-
TCP-fibrin scaffolds, it was observed that the normalized ratio of the fraction of AB 
reduction increased from Day 1 to Day 14 in all cases with one of the three samples 
(Donor 1) showing a further slight increase at Day 28, and Donor 1 and 2 demonstrating 
no further increase at Day 28 of induction for the cells seeded. In the case of mPCL-TCP-
collagen, a consistent decrease in normalized metabolic activity (osteo-induced over non-
induced) from Day 14 to Day 28 was observed for all three donors’ cell populations. 
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Fig. (1): Normalized fraction of Alamar Blue reduction (osteo-induced / non-induced). 
(a) ADSCs seeded in mPCL-TCP-fibrin scaffolds (b) ADSCs seeded in mPCL-TCP-
collagen scaffolds. Donors 1-3. (P1-P3). 
 
PicoGreen Assay: DNA Quantification 
The degree of cellular proliferation was assessed by DNA quantification using the 
picogreen assay for the mPCL-TCP-fibrin and mPCL-TCP-collagen scaffolds. The 
induced and non-induced groups are depicted for the mPCL-TCP-fibrin and mPCL-TCP-
collagen scaffold types on a donor to donor basis in Fig. (2a) to (2c), and (2d) to (2f) 
respectively. The induced samples were then expressed as a ratio of their non-induced 
counterparts as depicted in Fig. (2g) and (2h). The osteo-induced samples showed 
significantly higher proliferation (p < 0.05) than the non-induced groups at Day 14 of 
induction for both scaffold types. The absolute amount of total DNA increased 
significantly for non-induced groups between Day 14 to Day 28 (p < 0.05) for two out of 
the three donors cell populations in both the scaffold types. While the cell population 
from the same donor (patient 1) had an insignificant change (Fig 2 a and d). There were 
however no similar increases for the osteo-induced groups of both scaffold types from 
Day 14 to Day 28.  
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Fig. (2): DNA quantification as measured by Pico-green assay. Osteo-induced or non-
induced ADSCs seeded onto mPCL-TCP-fibrin scaffolds (a-c) or mPCL-TCP-collagen 
scaffolds (d-f). Donors 1-3. (P1-P3). Normalized ratio of DNA quantification (osteo-
induced / non-induced) for mPCL-TCP-fibrin scaffolds (g) and mPCL-TCP-collagen 
scaffolds (h). 
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Alkaline Phosphatase (ALP) Assay 
Both osteo-induced and non-induced groups in mPCL-TCP-collagen and mPCL-TCP-
fibrin scaffolds demonstrated an elevated ALP activity at Day 14, with significantly 
higher activity in the osteo-induced groups (p < 0.01) compared with their corresponding 
non-induced group as shown in Fig. (3). The ALP activity decreased thereafter till the 
end of the study period at Day 28 with a larger decrease in the induced groups compared 
to the non-induced groups. For the non-induced group, it was observed that the 
concentration of ALP remained relatively similar throughout the 28-day study period. 
The induced samples are expressed as a ratio of their non-induced counterparts in Fig. 
(3g) and (3h) and it can be seen that at Day 28 the ratio is less than 1 for all patients and 
scaffold types, reflecting the significant decrease in levels of expression in the induced 
groups compared to the non-induced groups from Day 14 to 28. 
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Fig. (3): Alkaline phosphatase (ALP) secretion from osteo-induced or non-induced 
ADSCs seeded onto mPCL-TCP-fibrin scaffolds (a-c) and mPCL-TCP-collagen scaffolds 
(d-f). Donors 1-3. (P1-P3). Normalized ratio of secreted ALP (osteo-induced / non-
induced) in mPCL-TCP-fibrin scaffolds (g) and mPCL-TCP-collagen scaffolds (h). 
 
Osteocalcin ELISA 
For both scaffold types, a similar trend was observed for both osteo-induced and non-
induced groups; the concentration of osteocalcin (OC) secreted into the supernatant was 
observed to increase gradually over the 28-days period, as shown in Fig. (4). However, 
Normalised ratio of alkaline phosphatase production by 
ADSCs seeded on mPCL-TCP-fibrin scaffolds (n=5)
Normalised ratio of alkaline phosphatase production by 
ADSCs seeded on mPCL-TCP-collagen scaffolds (n=5)
ALP vs Time PCL-TCP-collagen (P1) ALP vs Time PCL-TCP-collagen (P2)
ALP vs Time PCL-TCP-fibrin (P1) ALP vs Time PCL-TCP-fibrin (P2) ALP vs Time PCL-TCP-fibrin (P3)
ALP vs Time PCL-TCP-collagen (P3)
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the induced groups consistently showed higher OC secretion from Day 7 thereafter in 
both scaffold cases. Patient 1 (P1) demonstrated a large increase in OC secretion at Day 
21 for the non-induced ADSCs, without such a large associated increase for the 
osteoinduced ADSCs which affected the ratio shown in Figs. (4a) and (4b) (sudden 
decrease). At Day 28 the ratio was high again, as the osteoinduced ADSCs secreted a 
much higher OC level than the non-induced counterparts.  
 
Fig. (4): Osteocalcin (OC) secretion from osteo-induced or non-induced ADSCs seeded 
onto mPCL-TCP-collagen scaffolds (a-c) and mPCL-TCP-fibrin scaffolds (d-f).Donors 1-
3. (P1-P3). Normalized ratio of secreted OC (osteo-induced / non-induced) in mPCL-
TCP-fibrin scaffolds (g) and mPCL-TCP-collagen scaffolds (h). 
 
Normalised ratio of secreted osteocalcin from ADSCs 
seeded on mPCL-TCP-fibrin scaffolds (n=3) 
Normalised ratio of secreted osteocalcin from ADSCs 
seeded on mPCL-TCP-collagen scaffolds (n=3) 
OC vs Time PCL-TCP-collagen 
OC vs Time PCL-TCP-fibrin OC vs Time PCL-TCP-fibrin 
OC vs Time PCL-TCP-collagen OC vs Time PCL-TCP-collagen 
OC vs Time PCL-TCP-fibrin 
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Western Blot 
Western Blotting was performed to identify the expression of the osteogenic marker; 
osteonectin (ON). Osteonectin was expressed significantly in all 3 donors from the osteo-
induced group at Day 28 of induction for both scaffolds compared to the expression 
levels of housekeeping protein, ß-actin. In contrast, there was either no significant or very 
weak expression of ON in the non-induced group for mPCL-TCP-fibrin. (Fig. (5a)). 
ADSC from Donor 3 however appeared to demonstrate a very high ON expression on the 
mPCL-TCP-collagen scaffold in both osteo-induced and non-induced states (Fig. (5b)).  
 
 
 
Fig. (5): Western Blots from osteo-induced and non-induced ADSCs cultured for 28 days 
upon mPCL-TCP-fibrin (a) and mPCL-TCP-collagen scaffolds (b). Donors 1-3 (P1-P3). 
Osteonectin expression is significantly higher in induced groups. 
 
Light and Confocal Microscopy  
Light microscopy revealed cells had progressed from a rounded morphology on initial 
seeding (Fig. (6a,b,i,j) to a spindle-shaped morphology over a period of 7 days (Fig. 
(6c,d,k,l) respectively. The cells were embedded within the pores and multiple cell sheets 
a) mPCL-TCP-fibrin 
b) mPCL-TCP-collagen 
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were observed throughout the pores. Fig. (7a-h) show the ADSCs seeded within each 
respective scaffold at Day 14 and 28. Both mPCL-TCP-fibrin and mPCL-TCP-collagen 
scaffolds supported a large proportion of viable cells (green FDA stain) and few dead 
cells were observed (red PI stain) after 14 & 28 days for both the osteo-induced and non-
induced groups. ADSCs were seen to proliferate on the struts of scaffolds and across the 
pores in the form of overlapping cell sheets throughout the entire scaffold architecture 
(Fig. (7c,d) and (7g,f)).  
 
Fig. (6): Light microscopy showing ADSCs 3 hours post-seeding in mPCL-TCP-fibrin 
(a,) and mPCL-TCP-collagen scaffolds (i). Eight days post-seeding (Day 0) in mPCL-
TCP-fibrin (b) and mPCL-TCP-collagen (j) and then 7, 14 and 28 days post-seeding after 
undergoing osteo-induction (c, e, g, k, m, o). Or non-induced (d, f, h, l, n, p) on respective 
scaffolds.  
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Fig. (7): Confocal microscopy showing ADSCs seeded in the respective scaffolds. Green 
colour shows the live cells whereas red colour shows dead cells. Osteo-induced ADSCs 
seeded in mPCL-TCP-fibrin scaffolds at Day 14 (a).  Non-induced ADSCs seeded in 
mPCL-TCP-fibrin scaffolds at Day 14 (b). Osteo-induced ADSCs seeded in mPCL-TCP-
fibrin scaffolds at Day 28 (c). Non-induced ADSCs seeded in PCL-TCP-fibrin scaffolds 
at Day 28 (d). Osteo-induced ADSCs seeded in mPCL-TCP-collagen scaffolds at Day 14 
(e). Non-induced ADSCs seeded in mPCL-TCP-collagen scaffolds scaffolds at Day 14 (f). 
Osteo-induced ADSCs seeded in mPCL-TCP-collagen scaffolds at Day 28 (g). Non-
induced ADSCs seeded in mPCL-TCP-collagen scaffolds  at Day 28 (h). 
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Scanning Electron Microscopy (SEM) 
The surface topography and morphology of both mPCL-TCP-fibrin and mPCL-TCP-
collagen scaffold studies, based on the SEM images in Fig. (8a-h), revealed that ADSCs 
attached well to the surface of the mPCL-TCP scaffolds in both cases. Two major growth 
patterns, namely “bridging” and “cell sheet” formation were observed. Both osteo-
induced and non-induced groups within each scaffold type exhibited increasing degrees 
of “cell sheet” formation over time throughout the entire scaffold architecture. 
 
 
 
 
 
 
 
 
Fig. (8): Scanning Microscopic images. Osteo-induced ADSCs seeded in mPCL-TCP-
fibrin scaffolds at Day 14 (a). Non-induced ADSCs seeded in mPCL-TCP-fibrin scaffolds 
at Day 14 (b). Osteo-induced ADSCs seeded in mPCL-TCP-fibrin scaffolds,at Day 28 (c). 
Non-induced ADSCs seeded in mPCL-TCP-fibrin scaffolds at Day 28 (d). Osteo-induced 
ADSCs seeded in mPCL-TCP-collagen scaffolds scaffolds at Day 14 (e). Non-induced 
ADSCs seeded in mPCL-TCP-collagen scaffolds scaffolds, Day 14 (f). Osteo-induced 
ADSCs seeded in mPCL-TCP-collagen scaffolds scaffolds at Day 28 (g) non-induced 
ADSCs seeded in PCL-TCP-collagen scaffolds at Day 28 (h). 
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Discussion 
The work presented here aimed to investigate the osteogenic differentiation of ADSCs 
seeded in combination with fibrin or collagen matrices based on a well characterized 
PCL-TCP scaffold platform. Endres et al [9] used novel synthetic polymer/hydrogel 
matrices to look at osteogenic induction of human BMSCs and Li et al [10] investigated 
the multilineage differentiation potential of human BMSCs on 3D nanofibrous scaffolds 
fabricated from poly(ε-caprolactone) (PCL) in vitro.  They demonstrated that PCL-based 
scaffolds are able to fully support the multilineage differentiation of BMSCs, which 
further supported PCL’s suitability for bone tissue engineering. More recently, Hattori et 
al  [11] carried out an in vitro and in vivo study to compare the osteogenic and bone 
formation capacities of ADSCs and BMSCs using porous β-tricalcium phosphate (β-
TCP) as a 3D scaffold. Porous β-TCP can be gradually degraded and replaced by new 
bone, and when loaded with ADSCs or BMSCs, and incubated in osteogenic medium, the 
porous β-TCP scaffolds demonstrated excellent osteogenic characteristics.  
 
The mPCL-TCP scaffolds utilized in this study were fabricated via fused deposition 
modeling [12]. mPCL, being an aliphatic polyester has an unusually low glass transition 
temperature of -60°C and a low melting temperature of 60°C. In addition, another 
unusual property of mPCL is its high thermal stability; it has an exceptionally high 
decomposition temperature of 350°C. As a result of these properties, mPCL is very 
flexible and easy to process, making it an ideal material for the FDM fabrication 
technique. Most importantly, the mechanical properties of mPCL (Tensile strength of 
16MPa, tensile modulus of 400MPa, flexural modulus of 500MPa, elongation at yield of 
  23
7.0% & elongation at break at 80%) closely resemble that of human bone, making it a 
good candidate for bone tissue engineering [13]. The incorporation of TCP into the 
mPCL polymer matrix produces a composite material which further enhances the 
mechanical properties of porous mPCL polymer constructs [14]. Moreover, as shown in 
the study by Hattori et al [11] TCP facilitates cell attachment, proliferation and 
osteogenic differentiation of ADSCs. Most importantly, as TCP is resorbed, phosphate 
ions can buffer the acidic resorption by-products of mPCL to avoid the formation of an 
unfavourable acidic extracellular environment [15].  
 
In this study, human adipose tissue-derived stem cells (ADSCs) demonstrated the ability 
to be cultured in vitro within a 3D scaffold/matrix system for extensive periods with high 
viability as reflected in the alamar blue metabolic assay (Fig. (1a-b)) and confocal 
microscopy images (Fig. (7a-h)). At a porosity of 70%, the mPCL-TCP scaffold 
possesses a fully interconnected porous architecture, which can be seen from the SEM 
images (Fig. (8a-h)). This enabled a high diffusion of nutrients in and waste metabolites 
out of the construct, which is extremely crucial for the metabolism, proliferation and 
osteogenic differentiation of ADSCs. The incorporation of TCP resulted in a composite 
matrix with increased biocompatibility and creates a favorable surface for cellular 
attachment. In addition, seeding of ADSCs with fibrin glue and lyophilized collagen type 
I served to enhance the seeding efficiency and minimize the leaching of cells out of 
scaffolds; a common problem in tissue engineering applications. In the body, fibrin 
functions as a stimulant in bone healing, whilst collagen type I is the most abundant 
collagen type in bone. Both matrix systems not only allowed ADSCs to attach and 
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proliferate along the struts of scaffolds, but also within the pores via bridging as well as 
in the form of extensive overlapping cell sheets throughout the entire scaffold 
architecture. This is evident from the confocal and SEM images in Fig. (7) and Fig. (8) 
respectively. This bridging and overlapping of cell sheets are indicative of cellular in-
growth into the pores of the scaffolds similar (albeit to a lesser degree) of tissue in-
growth into spaces in vivo. 
 
ADSCs cultured with osteogenic supplements are stimulated to undergo osteogenic 
differentiation and behave differently from their non-induced counterpart. Osteogenesis is 
known to occur in 3 major phases, namely (1) proliferation, (2) extra-cellular matrix 
deposition and maturation and (3) mineralization. From the alamar blue assay data (Fig. 
(1)), the metabolic activity of the osteo-induced group is observed to be higher than that 
of the non-induced group at Day 14 time point for both studies. Similarly, the picogreen 
assay data (Fig. (2)) indicated a larger increase in the DNA quantity of the osteo-induced 
compared to the non-induced group at Day 14 time point for both scaffold types. 
However, over Day 14 and Day 28 time points, there was a marked increase in the DNA 
quantity for the non-induced group, whilst no such significant increase was observed for 
the induced group. A possible explanation for these trends is that the osteogenic 
supplements initially caused ADSC in the osteo-induced group to increase their 
proliferation rate before stimulating them to differentiate along the osteogenic lineage, 
with a concomitant reduction in proliferation, commonly associated with differentiation. 
The metabolic activity of the induced groups increased as a result of cellular division up 
to the early Day 14 time point whilst that of the non-induced group remained slightly 
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above the basal level. At the same time, the DNA quantity of the osteo-induced group is 
significantly higher than that of the non-induced group due to the increase in the number 
of cells. After Day 14 time point, ADSCs in the induced group have reached their 
optimum population density within the scaffolds, and thus started their differentiation 
along the osteogenic lineage. As a result, there was no further increase in metabolic 
activity and DNA quantity over Day 14 and Day 28 time points. This is in accordance 
with the reciprocal relationship which is known to exist between proliferation and 
differentiation along the osteogenic phenotype, as described by Owen et al [16]. On the 
other hand, the non-induced group showed a significant increase in DNA quantity over 
Day 14 and Day 28 time points, indicating a continuous proliferation. ADSCs in the non-
induced group, not given osteogenic supplementation, continued to proliferate at a basal 
level over the 28-day period until they reached their optimum population density, this 
was supported by their low differentiation reflected in subsequent assays. 
 
Alkaline phophastase (ALP) in serum is an early osteoblastic ectoenzyme, which plays a 
role in matrix mineralization [17]. From the ALP assay data (Fig. (3)), an initial spike in 
ALP concentration was observed at the early Day 14 time point for the induced group in 
both scaffold groups, thus indicating that ADSCs from the induced group started to 
undergo initial osteogenic differentiation, in which they started to form extra-cellular 
matrices. Furthermore, osteocalcin (OC), also known as bone Gla protein, is a calcium-
binding protein which is a major component of the non-collagenous bone matrix and is a 
late osteogenic marker. OC is mainly produced by osteoblasts and is crucial for bone 
extra-cellular matrix mineralization [4]. From the OC ELISA data (Fig. (4)), OC 
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concentration increased gradually over the 28-day period for the induced group in both 
scaffold groups, thus indicating that ADSCs from the induced group produced more 
osteo-related proteins. This could be attributed to the osteogenic supplements playing 
their role as well as the favorable mPCL-TCP scaffold material surface, which is 
osteoconductive [18,19].  However, it was observed that the non-induced group also 
exhibited a slight, though not significant increase in OC concentration over time (Fig. 
(4)). A possible hypothesis could be that the TCP component in the scaffolds might have 
induced the ADSCs of the non-induced group towards osteogenesis [18,19]. 
 
As the ADSC underwent differentiation along the osteogenic lineage, they formed and 
deposited extra-cellular matrices and related proteins such as OC, osteonectin (ON) and 
osteopontin (OP). These non-collagenous matrix proteins play important roles in bone 
matrix mineralization [16]. Protein quantification data indicated (data not shown), the 
amount of proteins extracted and quantified for the osteo-induced group was significantly 
higher than that of the non-induced group at both Day 14 and Day 28 time points in both 
scaffold studies. This could be attributed to the secretion of these non-collagenous matrix 
proteins by ADSCs from the osteo-induced group, which were undergoing osteogenic 
differentiation. This hypothesis was substantiated with results from Western blots (Fig. 
(5a-b)). ON is found in preosteoblasts, osteoblasts, osteocytes, and newly formed osteoid 
in matrix. This protein is the first osteogenic marker characterized in the matrix formation 
phase and has the ability to bind to collagen and promote hydroxyapatite formation in 
vitro [18]. From the results obtained, ON was expressed significantly by ADSCs from all 
3 donors of induced groups at Day 28 time points for both scaffolds, whilst there were 
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either no significant or very weak expression of ON by the non-induced ADSCs for both 
scaffold types, except in the case of Donor 3, whose cells showed a high ON expression 
in both the osteo-induced and non-induced states when collagen was used as the scaffold 
matrix component. This may be attributable to donor to donor variability. Alternatively, 
as ON is known to bind to collagen prior to producing mineralized matrix, this matrix 
may likely be more conducive to up-regulation of ON expression as it partially mimics its 
natural environment. In turn, this may direct the non-induced cells down the osteogenic 
lineage faster, with a faster onset of differentiation when ADSC are in contact with 
collagen than for the ADSCs present within a fibrin matrix. Generally, the results from 
the western blots indicated that ADSCs from the osteo-induced group were indeed 
undergoing the initial stage of extra-cellular matrix formation and deposition.  
 
In this study, human adipose tissue-derived stem cells demonstrated their ability to be 
cultured in vitro within three dimensional mPCL-TCP scaffolds for extensive periods 
spanning over 4 weeks with relatively high viability. In addition, both the fibrin glue and 
collagen type I were found to be effective matrices. Light, SEM and confocal imaging 
revealed good adherence of ADSCs to the osteoconductive mPCL-TCP scaffold surfaces 
in the form of bridging and overlapping cell sheets, as well as good viability of ADSCs 
within both types of scaffold matrix systems. Under osteogenic differentiation 
supplementation, ADSC within the 3D scaffold constructs underwent osteogenesis in 
distinct phases. This was verified by results from the various assays including 
alamarBlue, picogreen, alkaline phosphatase, osteocalcin ELISA, and western blots 
which indicated that ADSCs underwent initial cellular proliferation for the 1st 2 weeks of 
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culture before they started to form and deposit extra-cellular matrices during the 
subsequent  2 weeks of culture.  
 
The overall results of this study substantiated the potential of ADSCs as a source of 
osteogenically-capable progenitor cells, and the suitability of both fibrin and collagen 
mPCL-TCP scaffold types as a suitable vehicle for regenerative medicine applications, 
such as bone tissue engineering. This study has provided the motivation to conduct 
further in vivo studies to examine the cellular behavior of human ADSCs in these 
scaffolds after surgical implantation into small and subsequent large animal models, with 
the ultimate aim of developing a successful composite scaffold for regenerative medicine 
applications. 
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